Scientific and business development for the vaccine industry

 

World Vaccine Congress Europe

  • Delve into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants
     
  • Hear clinical phase I, II and III data from leading biotechs and big pharma
     
  • Gain updates on the latest discovery-stage prophylactic and therapeutic vaccines
     
  • Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future vaccines

Download the brochure

 

Should you sponsor?

Why get involved?

Find out more about how you can promote your products at the vaccines sector’s premier event by downloading the sponsorship brochure today. 

 

Why sponsor?

  • Speak to a room full of vaccine experts
  • Host a roundtable and meet your customers
  • Let us organise 1-2-1 meetings for you
  • Let us generate sales leads pre-event
  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Educate your target market
  • Generate new sales leads
  • Raise brand profile

Get the sponsorship brochure

Over 50 innovative companies on display

 

  • Showcase Sponsor

    Lipotek Pty Ltd at World Vaccine Congress Europe
  • Sponsor

    SGS Belgium NV at World Vaccine Congress Europe
  • Exhibitor

    BioKinetic Europe at World Vaccine Congress Europe
  • Exhibitor

    3M Health Care Ltd at World Vaccine Congress Europe
  • Exhibitor

    Viro Cyt at World Vaccine Congress Europe
  • Exhibitor

    Teleflex Medical at World Vaccine Congress Europe
  • Exhibitor

    F.E.F. Chemicals As at World Vaccine Congress Europe

Join them

 

Interactive Sessions Offer High Level Networking

 

World Vaccine Congress Europe

“The excellent program, the quality of the speakers and their relevance for the field. In terms of commercial opportunities, the former provides an opportunity to engage with the relevant leader.” 
ExpreS2ion Biotechnologies

World Vaccine Congress Europe

“Great networking opportunity and the level of technical talks is well targeted”
Sanofi Pasteur

World Vaccine Congress Europe

“Well organised, interesting sessions, high calibre attendees supporting good networking opportunities”
MedImmune

 

Co-located with

Be part of the conversation

 

CMO

Top 10 vaccine CMOs

The development of a new vaccine is a complex venture. Biotech and pharmaceutical companies are increasingly choosing to outsource their manufacturing efforts, as partnering with the right CMO can streamline this process. Since 2011, total global spending on contract manufacturing reached $31.9 billion according to a 2012 industry report entitled, “The CMO Market Outlook to […]

The post Top 10 vaccine CMOs appeared first on Vaccine Nation.

PaxVax logo

PaxVax Announces Primary Endpoints Met in Phase 3 Cholera Vaccine Trial

Positive Lot-to-Lot Consistency Data Pave Way for Biologics License Application (BLA) Submission in 2015 December 8, 2014 PaxVax Inc., a specialty vaccine company focused on travel and biodefense, today announced positive results from a Phase 3 safety and lot-to-lot consistency trial of its single-dose oral cholera vaccine candidate, PXVX0200, which utilizes the same attenuated vaccine […]

The post PaxVax Announces Primary Endpoints Met in Phase 3 Cholera Vaccine Trial appeared first on Vaccine Nation.

CEL-SCI Corporation

CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites

Sites in Europe and Asia add to patient enrollment and position Company to apply for global regulatory approvals December 8, 2014 CEL-SCI Corporation today announced that during November it has added seven new clinical sites to its global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). Patient screening […]

The post CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites appeared first on Vaccine Nation.

Join the Community

Strategy and innovation in vaccines

Sign Up to Our Newsletter